Carolyn T Bramante

About Carolyn T Bramante

Carolyn T Bramante, With an exceptional h-index of 26 and a recent h-index of 24 (since 2020), a distinguished researcher at University of Minnesota-Twin Cities, specializes in the field of Obesity, obesity-related co-morbidities, health disparities.

His recent articles reflect a diverse array of research interests and contributions to the field:

The power and pressure placed on clinicians and guideline panels

Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of Coronavirus Disease 2019

A Comparison of Recruitment Methods for a Remote, Nationwide Clinical Trial for Covid-19 Treatment

SMART use of medications for the treatment of adolescent severe obesity: A sequential multiple assignment randomized trial protocol

Efficacité de la metformine en prévention d’un covid long chez les patients non hospitalisés avec excès pondéral? A confirmer!

COVID-19 outcomes in persons with hemophilia: results from a US-based national COVID-19 surveillance registry

Development of a definition of postacute sequelae of SARS-CoV-2 infection

Metformin reduces sars-cov-2 in a phase 3 randomized placebo controlled clinical trial

Carolyn T Bramante Information

University

Position

___

Citations(all)

2354

Citations(since 2020)

2200

Cited By

363

hIndex(all)

26

hIndex(since 2020)

24

i10Index(all)

39

i10Index(since 2020)

38

Email

University Profile Page

Google Scholar

Carolyn T Bramante Skills & Research Interests

Obesity

obesity-related co-morbidities

health disparities

Top articles of Carolyn T Bramante

The power and pressure placed on clinicians and guideline panels

The Lancet Infectious Diseases

2024/1/1

Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of Coronavirus Disease 2019

Clinical Infectious Diseases

2024/5/1

A Comparison of Recruitment Methods for a Remote, Nationwide Clinical Trial for Covid-19 Treatment

Open Forum Infectious Diseases

2024/4/29

SMART use of medications for the treatment of adolescent severe obesity: A sequential multiple assignment randomized trial protocol

Contemporary Clinical Trials

2024/3/1

Carolyn T Bramante
Carolyn T Bramante

H-Index: 10

Efficacité de la metformine en prévention d’un covid long chez les patients non hospitalisés avec excès pondéral? A confirmer!

Minerva

2024

Metformin reduces sars-cov-2 in a phase 3 randomized placebo controlled clinical trial

medRxiv

2023/6/7

Risk of severe acute respiratory syndrome coronavirus 2 infection among women with polycystic ovary syndrome

The Journal of Infectious Diseases

2022/7/15

Does COVID-19 infection increase the risk of diabetes? Current evidence

2023/8

68 Metformin prevents the diagnosis of Long Covid in phase 3 trial of early treatment.

Journal of Clinical and Translational Science

2023/4

Metformin for treatment of acute COVID-19: systematic review of clinical trial data against SARS-CoV-2

2023/7/1

Carolyn T Bramante
Carolyn T Bramante

H-Index: 10

Proteomic pathways associated with developing severe disease for patients with COVID-19: A biologic analysis of data from two multicenter randomized controlled trials …

Journal of Critical Care

2023/4/1

SARS-CoV-2 infection is associated with intestinal permeability, systemic inflammation, and microbial dysbiosis in hospitalized COVID-19 patients

bioRxiv

2023

Strategies used for the COVID-OUT decentralized trial of outpatient treatment of SARS-CoV-2

Journal of Clinical and Translational Science

2023/1

1289-P: Predictors of New-Onset Type 2 Diabetes after Infection with COVID-19 in the COVID-OUT Randomized Trial

NaN

2023

Metformin Reduced SARS-CoV-2 Viral Load in a Phase 3 Randomized Clinical Trial

Topics in Antiviral Medicine

2023

See List of Professors in Carolyn T Bramante University(University of Minnesota-Twin Cities)